Middle East and Africa Leukapheresis Market
No. of Pages: 121 | Report Code: TIPRE00025792 | Category: Life Sciences
No. of Pages: 121 | Report Code: TIPRE00025792 | Category: Life Sciences
The Middle East & Africa Leukapheresis market is analyzed based on three large countries: Saudi Arabia, the UAE, South Africa, and Rest of MEA. Saudi Atabia is contributing a major share in the growth of leukapheresis market. Saudi Arabia is one of the fastest-growing regions in the Middle East & Africa, which is being driven by a huge population base and increasing acceptance of medical devices. To achieve Vision 2030, the government of Saudi Arabia launched a National Transformation Program in 2016. The government had launched this program for the overall development of Saudi Arabia across all industries. In addition, this program is linked to the implementation of primary and digital infrastructure projects in several industries. Under this program, the government focuses on consolidating and transforming the health system by increasing the accessibility of health services, improving health efficiency and quality, and preventing chronic diseases. This government-approved strategic policy creates lucrative medical device launch opportunities that will ultimately fuel the Leukapheresis market growth in Saudi Arabia over the forecast period. Increased awareness of health issues and increased consumption of health services contribute to a significant market for medical devices.
Middle East & Africa have been witnessing a growing number of COVID-19 cases since its outbreak. Economic uncertainties and ongoing conflicts are worsening the condition in the region. For instance, countries such as Syria, Libya, and Yemen are suffering violent conflict and cannot implement any public health measures. Iran was in deep economic recession due to the US sanctions. Also, the major source of economic stabilization in Middle East countries is oil production and export. However, the recent pandemic is causing turbulence to the economies of the Middle East region. Further, the adoption of plasma therapy for covid patients is impacting the market in the positive way. UAE is turning to a century-old treatment for viral disease that is showing promise with patients. Known as Convalescent Plasma therapy, it involves taking virus-killing antibodies from the blood of people who have recovered from the disease and donating them to the critically ill. With anti-virals still undergoing human trials and a vaccine at least a year away, CP therapy is being seen as a vital stopgap measure against the pandemic in the region. On April 12, 2020, medics at Sheikh Khalifa Medical City in Abu Dhabi announced that they were treating a patient with the plasma of an Emirati who had recovered from the virus.
Strategic insights for the Middle East and Africa Leukapheresis provides data-driven analysis of the industry landscape, including current trends, key players, and regional nuances. These insights offer actionable recommendations, enabling readers to differentiate themselves from competitors by identifying untapped segments or developing unique value propositions. Leveraging data analytics, these insights help industry players anticipate the market shifts, whether investors, manufacturers, or other stakeholders. A future-oriented perspective is essential, helping stakeholders anticipate market shifts and position themselves for long-term success in this dynamic region. Ultimately, effective strategic insights empower readers to make informed decisions that drive profitability and achieve their business objectives within the market.
| Report Attribute | Details |
|---|---|
| Market size in 2021 | US$ 3.77 Million |
| Market Size by 2028 | US$ 6.20 Million |
| Global CAGR (2021 - 2028) | 7.4% |
| Historical Data | 2019-2020 |
| Forecast period | 2022-2028 |
| Segments Covered |
By Product Type
|
| Regions and Countries Covered | Middle East and Africa
|
| Market leaders and key company profiles |
The geographic scope of the Middle East and Africa Leukapheresis refers to the specific areas in which a business operates and competes. Understanding local distinctions, such as diverse consumer preferences (e.g., demand for specific plug types or battery backup durations), varying economic conditions, and regulatory environments, is crucial for tailoring strategies to specific markets. Businesses can expand their reach by identifying underserved areas or adapting their offerings to meet local demands. A clear market focus allows for more effective resource allocation, targeted marketing campaigns, and better positioning against local competitors, ultimately driving growth in those targeted areas.
The leukapheresis market in Middle East & Africa is expected to grow from US$ 3.77 million in 2021 to US$ 6.20 million by 2028; it is estimated to grow at a CAGR of 7.4% from 2021 to 2028. Blood diseases disturb the overall well-being of patients. Anemia; hemophilia; von Willebrand disease (VWD); blood cancers such as myeloma, leukemia, and lymphoma are among the common blood diseases. The number of newly diagnosed leukemia cases increased from 354,500 in 1990 to 518,500 in 2017. Further, according to the National Heart, Lung, and Blood Institute, anemia affects more than 3 million Americans every year, while as per the WHO, it affects ~1.62 billion people worldwide. According to the Centers of Disease Control and Prevention (CDC), hemophilia A affects ~1 in 5,000 male births. The CDC survey for 2017 reported that Von Willebrand disease (VWD), one of the most commonly occurring bleeding disorders, affects up to 1% of the population. More than 14,600 men, women, and children were seen at hemophilia treatment centers for the treatment of VWD during 2012–2016. The rising incidence of these diseases maximizes the need for blood transfusion, thereby bolstering the demand for leukapheresis equipment. Two of the most common types of apheresis used for the removal of harmful substances from blood are cytapheresis and plasma exchange. Plasma exchange is used to treat disorders such as myasthenia gravis, thrombotic thrombocytopenic purpura, and multiple sclerosis. Cytapheresis, a process that removes the excess number of blood cells, is used in the treatment of leukemia, polycythemia, and thrombocythemia, among others.
In terms of product type, the leukapheresis disposables segment held a larger share in 2021. Based on application, research applications segment held the largest share in 2021. Based on end user, blood component providers and blood centers segment held the largest share in 2021.
A few major primary and secondary sources referred to for preparing this report on the leukapheresis market in Middle East & Africa are company websites, annual reports, financial reports, national government documents, and statistical database, among others. Major companies listed in the report are Asahi Kasei Corporation; Fresenius SE & Co. KGaA; Haemonetics Corporation; Terumo Corporation; STEMCELL Technologies Inc.; HemaCare; Macopharma; AllCells; and BioIVT among others.
The Middle East and Africa Leukapheresis Market is valued at US$ 3.77 Million in 2021, it is projected to reach US$ 6.20 Million by 2028.
As per our report Middle East and Africa Leukapheresis Market, the market size is valued at US$ 3.77 Million in 2021, projecting it to reach US$ 6.20 Million by 2028. This translates to a CAGR of approximately 7.4% during the forecast period.
The Middle East and Africa Leukapheresis Market report typically cover these key segments-
The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the Middle East and Africa Leukapheresis Market report:
The Middle East and Africa Leukapheresis Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:
The Middle East and Africa Leukapheresis Market report is valuable for diverse stakeholders, including:
Essentially, anyone involved in or considering involvement in the Middle East and Africa Leukapheresis Market value chain can benefit from the information contained in a comprehensive market report.
Office No. 1011, First floor, Farena Corporate Park, Magarpatta-Mundhwa road, Pune - 411028, Maharashtra, India
UK+442030260021, US:+16467917070
sales@businessmarketinsights.com
Get Free Sample For Middle East and Africa Leukapheresis Market
